SureTrader SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 35
Posts 7,134
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/27/2016 6:02:26 AM
Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer "Business Wire" - 9/26/2016 5:00:00 PM
Navidea Achieves $1 Million in Lymphoseek® Commercial Milestones "Business Wire" - 9/22/2016 6:59:00 AM
Navidea’s Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial "Business Wire" - 9/16/2016 8:15:00 AM
Navidea's Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial "PR Newswire (US)" - 9/16/2016 8:15:00 AM
Navidea to Present at Upcoming Investor Conferences "Business Wire" - 9/14/2016 7:00:00 AM
Navidea Biopharmaceuticals to Hold Investor Update Call "Business Wire" - 9/6/2016 3:21:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2016 8:20:50 AM
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek® in North America "Business Wire" - 9/6/2016 6:59:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/31/2016 9:30:12 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2016 5:16:58 PM
Navidea Biopharmaceuticals Announces 2016 Annual Meeting Results "Business Wire" - 8/11/2016 5:00:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2016 4:04:57 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/10/2016 3:44:00 PM
Navidea Executes a Term Sheet with Cerveau Technologies to Sublicense NAV4694 "Business Wire" - 8/8/2016 5:00:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/4/2016 7:09:42 AM
Navidea Reports Second Quarter 2016 Financial Results "Business Wire" - 8/4/2016 6:59:00 AM
Navidea Biopharmaceuticals to Announce Second Quarter 2016 Financial Results on August 4, 2016 "Business Wire" - 7/28/2016 10:15:00 AM
Navidea Receives IRB Approval for its Lymphoseek® Rheumatoid Arthritis Clinical Trial Protocol "Business Wire" - 7/19/2016 6:59:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/18/2016 5:14:23 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/7/2016 4:45:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/7/2016 4:44:08 PM
Why Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics "PR Newswire (US)" - 7/5/2016 7:45:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 7/1/2016 12:26:45 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/1/2016 12:24:52 PM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 8906 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist